COMPARATIVE EFFICACY OF THREE PROTOCOLS FOR THE
TREATMENT OF HAEMORRHAGIC SEPTICAEMIA IN BUFF ALOES AND CATTLE
M. Ashraf Raza, G. Muhammad, M. Athar and M.
Zargham Khan
Faculty of Veterinary Science,
University
of
Agriculture,
Faisalabad38040,
Pakistan
Abstract
A total of 50 animals (39 buffaloes and 11
cattle) suffering from haemorrhagic septicaemia (H.S.), selected from the field,
were divided into 3 groups {A, B, C) and assigned randomly to either of three
treatment protocols viz. A, Band c. Group A {20 animals) was treated with
protocol A i.e. norfloxacin (Norfloxillin; Tarobina) + diclofel1ac sodium +
Novacoc forte (Richter Pharma). Group B (20 animals) was treated with protocol B
which was essentially the same as protocol A except that Novacoc forte was
omitted. Group C (10 animals; control) was treated with one of conventional
therapies of H.S. i.e. gentamicin + dipyron. The disease severity index of study
animals under each treatment protocol was recorded at 0, 12, 24, 48, and 72
hours from the start of treatment. All the treatments were started after
application of cold water on head for 15 minutes. The treatment was repeated at
12, 24 and 48 hours after start of treatment as the situation warranted. The
survival per cent was 85, 80 and 30 amongst animals treated respectively with
protocol A, Band C. Three animals in group A and 2 in group B died after
recovering completely. Excluding these animals from the recovered ones
translated into net survival (percentage) of 70, 70, and 30 in group A, B, and
C, respectively. In terms of reduction of severity of disease, there was
significance difference {P ≤ 0.05) between protocol C and A and between protocol
C and Bat 12 and 48 hours after treatment but there was non-significant
difference at hour 24. Both treatment protocols A and B exploiting the use of a
quinolone {norfloxacin) plus a non-steroidal anti- inflammatory drug (diclofenac
sodium) with or without a toxin neutralizer and circulatory-stimulant (Novacoc
forte) were more effective than one of the conventional treatments i.e.
gentamicin + dipyron for the treatment of H.S.